Showing results (271-280 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|April 8, 2018
Evaluation of dystonia in children and adolescents treated with atomoxetine within the Truven MarketScan database: a retrospective cohort studyKristin J Meyers, Himanshu P Upadhyaya, Robert Goodloe, et al.Expert Opinion on Drug Safety|June 9, 2018
Anakinra for the treatment of rheumatoid arthritis: a safety evaluationJulio Ramírez, Juan D CañeteExpert Opinion on Drug Safety|June 9, 2018
Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional studyXuemei Zhang, Rui Niu, Bianling Feng, et al.Expert Opinion on Drug Safety|June 30, 2017
Safety of ixazomib for the treatment of multiple myelomaAntoine Bonnet, Philippe MoreauExpert Opinion on Drug Safety|June 5, 2019
Benefits versus risk profile of buparlisib for the treatment of breast cancerAnne Patsouris, Paule Augereau, Jean-Sebastien Frenel, et al.Expert Opinion on Drug Safety|September 8, 2018
Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative reviewFahadullah Khan, Mohammad Ismail, Qasim Khan, et al.Expert Opinion on Drug Safety|June 1, 2019
An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitorsElizabeth Mary Lamos, Maka Hedrington, Stephen N DavisExpert Opinion on Drug Safety|May 18, 2019
Safety and tolerability of injectable lipid-lowering drugs: an update of clinical dataLarysa Strilchuk, Federica Fogacci, Arrigo Fg CiceroExpert Opinion on Drug Safety|May 7, 2019
An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritisMariana Luís, João Freitas, Flávio Costa, et al.Expert Opinion on Drug Safety|May 11, 2019
Drug safety evaluation of aripiprazole in bipolar disorderAlessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, et al.Pageof 281